These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27793002)

  • 1. Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.
    Jue C; Zhifeng W; Zhisheng Z; Lin C; Yayun Q; Feng J; Hao G; Shintaro I; Hisamitsu T; Shiyu G; Yanqing L
    Oncotarget; 2016 Nov; 7(47):77987-77997. PubMed ID: 27793002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
    Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
    J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on vasculogenic mimicry in hepatocellular carcinoma].
    Zhao XL; Du J; Zhang SW; Liu YX; Wang X; Sun BC
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):41-4. PubMed ID: 16420764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma.
    Sun B; Zhang S; Zhang D; Du J; Guo H; Zhao X; Zhang W; Hao X
    Oncol Rep; 2006 Oct; 16(4):693-8. PubMed ID: 16969481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.
    Guzman G; Cotler SJ; Lin AY; Maniotis AJ; Folberg R
    Arch Pathol Lab Med; 2007 Dec; 131(12):1776-81. PubMed ID: 18081435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
    Zheng N; Zhang S; Wu W; Zhang N; Wang J
    Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Notch1 with vasculogenic mimicry in human hepatocellular carcinoma cell lines.
    Zhu MS; Xu LB; Zeng H; Shi XD; Wu WR; Liu C
    Int J Clin Exp Pathol; 2014; 7(9):5782-91. PubMed ID: 25337219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.
    Shao B; Zhao X; Liu T; Zhang Y; Sun R; Dong X; Liu F; Zhao N; Zhang D; Wu L; Wang Y; Wang M; Meng J; Lin X; Sun B
    J Cell Mol Med; 2019 Feb; 23(2):1363-1374. PubMed ID: 30506621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
    Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
    Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three-dimensional cell culture and histology of vasculogenic mimicry in hepatocellular carcinoma].
    Zhao J; Huang JS; Yang AJ; Wang CY; Liu W; Li M
    Ai Zheng; 2007 Feb; 26(2):123-6. PubMed ID: 17298738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion.
    Shirabe K; Kajiyama K; Harimoto N; Masumoto H; Fukuya T; Ooya M; Maehara Y
    World J Gastroenterol; 2009 Jun; 15(21):2632-7. PubMed ID: 19496194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.
    Zhao N; Sun BC; Zhao XL; Wang Y; Meng J; Che N; Dong XY; Gu Q
    Int J Clin Exp Pathol; 2015; 8(12):15759-68. PubMed ID: 26884845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio.
    Shirabe K; Kajiyama K; Abe T; Sakamoto S; Fukuya T; Akazawa K; Morita K; Maehara Y
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1431-6. PubMed ID: 19486447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
    Cheng R; Cai XR; Ke K; Chen YL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Hepatic Resection for Hepatocellular Carcinoma Associated with Portal Vein Invasion.
    Shehta A; Farouk A; Elghawalby AN; Elshobary M; Aboelenin A; Fouad A; Ali MA
    J Surg Res; 2021 Oct; 266():269-283. PubMed ID: 34038849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
    Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
    Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.
    Liu W; Xu G; Ma J; Jia W; Li J; Chen K; Wang W; Hao C; Wang Y; Wang X
    Tohoku J Exp Med; 2011 May; 224(1):29-39. PubMed ID: 21512310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Expression of NTN4 and Its Receptors in Patients with Hepatocellular Carcinoma.
    Vennela J; Pottakkat B; Vairappan BS; Verma SK; Mukherjee V
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4285-4292. PubMed ID: 38156865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.
    Liu WB; Xu GL; Jia WD; Li JS; Ma JL; Chen K; Wang ZH; Ge YS; Ren WH; Yu JH; Wang W; Wang XJ
    Med Oncol; 2011 Dec; 28 Suppl 1():S228-38. PubMed ID: 20957524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.